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A B S T R A C T
Background: Functional Somatic Symptoms (FSS) are symptoms for which an underlying pathology cannot be
found. High negative affect (NA) has been linked to the etiology of FSS, but little is known about the role of
Positive Affect (PA).
Objective: The aim of this study was to test if PA is related to current and future lower levels of FSS. We also
examined the interactions between PA and NA, and PA and sex on FSS.
Method: Data from the Dutch Tracking Adolescents' Individual Lives Survey (TRAILS) cohort were used
(N=1247 cases, 60% females, mean age T5=22.2, T6=25.6). PA was measured with the PANAS schedule
and FSS with the Adult Self Report questionnaire (ASR). A Principal Component Analysis (PCA) was performed
on the physical complaints subscale of the ASR. Regression analyses with bootstrapping were performed to assess
the associations and interactions.
Results: PA had a significant negative association with current FSS when adjusted for NA, age, sex and socio-
economic status (B=−0.004; BCa 95% CI= [−0.006; −0.002]), but the association was not significant
longitudinally. No interactions were found. In secondary analysis, PA was significantly related to the component
“General Physical Symptoms” (B=−0.019; BCa 95% CI= [−0.0028; −0.011]) but not to the component
“Gastrointestinal Symptoms” (B=−0.008; BCa 95% CI= [−0.016;0.001]) in the cross-sectional analysis.
Conclusion: In conclusion, high PA was significantly related to current lower levels of FSS, but the effect was
small. Further research on individual variations in affect is needed to obtain more insight in their contribution to
FSS.
1. Introduction
Functional Somatic Symptoms (FSS) are symptoms for which an
underlying pathology cannot be found. These cover a constellation of
symptoms that include, amongst others, fatigue, dizziness, headache,
abdominal pain, and musculoskeletal pain [1,2]. Around 33% of the
symptoms in consultations with general practitioners remain un-
explained by a pathology, and between 20% and 25% of these symp-
toms become chronic or recurrent [2]. Almost 25% of all adolescents
and young adults report FSS [3,4]. These symptoms lead to difficulties
in adolescents' and young adults lives, such as impaired daily physical
and social activities, school absenteeism [5–7] and a higher risk of
developing mental illnesses in adulthood [8].
The etiology of FSS remains unclear as it involves multiple phy-
siological, psychological and social factors that interact with each other
[1,9]. Nevertheless, previous studies have highlighted a consistent re-
lationship between high Negative Affect (NA) and FSS [10–12]. For
example, studies have shown that people with many FSS have a higher
frequency of NA states compared with those with fewer FSS [13,14].
Although high NA could be considered a consequence of FSS, studies in
children and adolescents have suggested that it is a risk factor rather
than a result of the symptoms [15,16]. In addition, research shows that
depression and anxiety [16–18], as well as neuroticism, and trait an-
xiety [11,19,20], which are characterized by high levels of NA, are
strongly related to FSS.
Although high NA has been associated with more FSS, the role of
Positive Affect (PA) in FSS is not well known. As PA and NA represent
two different affective state dimensions, rather than two opposite poles
from the same dimension [21], we cannot assume that high PA has the
same effects on FSS as low NA. High PA is defined as a state of high
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energy, full concentration, and pleasurable engagement while low NA is
a state of calmness and serenity [21].
Nowadays, media and advertisement encourage having high PA as a
way to prevent and fight diseases. Several studies have attempted to
address these issues empirically. A meta-analysis [22] pointed out that
PA is related to a reduced mortality risk in healthy and diseased po-
pulations. Longitudinal studies have found that increased PA is related
to lower incident coronary heart disease [23], a smaller probability to
be diagnosed with hypertension or diabetes [24,25], and with lower
levels of Allostatic Load, which is a system of inflammatory, cardio-
vascular and metabolic markers associated with stress [26]. However,
results are not conclusive and it is necessary to explore to what extent
PA influences health outcomes [27]. Regarding FSS, one study in a
primary care population of 377 adult patients experiencing somatic
symptoms without organic cause found that PA independently con-
tributed to the variance in FSS at a cross-sectional level, after control-
ling for gender, neuroticism, alexithymia, and negative affect. After six
months, participants who reported a decrease in PA compared to
baseline had a 41% increase in the number of FSS [28,29]. Besides the
mentioned study, research on the longitudinal association of PA and
FSS is scarce and there are no studies exploring these associations in
non-clinical cohorts. As FSS appear to be highly influenced by psy-
chological states, and young adulthood is a critical period for mental
health, addressing the relationship between PA and FSS in a large non-
clinical cohort of young adults can give insight in the influence of PA on
the development of FSS.
It has been suggested that a mood state characterized by the com-
bination of low PA and high NA is associated to more general physical
symptoms than only low PA or high NA [14,30], indicating that PA and
NA might have an interactive effect on FSS. Sex differences have also
been found in the association between PA and symptoms related to FSS.
Males appear to be more sensitive than females to the effects of PA on
clinical pain [31], and females appear to be more sensitive to the effects
of PA on Allostatic Load [26].
The main aim of this study is to test if PA is related to FSS and if it
can predict changes in the levels of FSS longitudinally, in young adults
from the Tracking Adolescents' Individual Lives Survey (TRAILS) cohort
study. We also want to test if sex and NA each interact with the effect of
PA on FSS. Additionally, a previous study suggested that FSS in ado-
lescents could be divided in two dimensions: one consisting of headache
and gastrointestinal symptoms, and the other consisting of over-
tiredness, dizziness and musculoskeletal pain. Therefore, we aimed to
explore the dimensionality of FSS in young adults as well, to assess
whether the relationship between PA and FSS differs across FSS di-
mensions [32]. We hypothesize that high PA in young adulthood is
associated with current lower levels of FSS, and with a lower risk of
developing or increasing levels of FSS over time. Based on previous
studies we also hypothesize that high PA in combination with low NA
has a stronger effect on the variations of FSS than high PA alone and
that males are more sensitive than females to the effect of PA on FSS.
2. Method
2.1. Participants
The participants of this study are part of the Tracking Adolescents'
Individual Lives Survey (TRAILS) cohort study. TRAILS is an ongoing
prospective cohort study of adolescents from the north of the
Netherlands [33]. It consists of a population cohort of 2230 adolescents
at baseline (T1), which has been followed from the age of 11 (mean age:
11.1, SD=0.6) [34]. TRAILS participants have been assessed six times
to date during a period of 15 years with 2 to 3 years in between. The
sampling procedure is described elsewhere [33]. Data from the fifth
(T5) and sixth (T6) waves were used in this study. Respondents parti-
cipated in T6 3.4 years after participating in T5. The official response
rate was 79.7% (n=1.778) of the baseline participants (n=2230) at
T5, and 72.6% (n=1618) of the baseline participants at T6.
2.2. Measures
2.2.1. Functional somatic symptoms
FSS were measured at T5 and T6 with the Physical Complaints
subscale of the Adult Self-Report questionnaire (ASR) [35]. The Phy-
sical Complaints subscale includes 12 items referring to somatic com-
plaints, which the participants report as symptoms without a medical
cause in the past six months. The items ask if the participants ‘never’
(0), ‘sometimes or a bit’ (1), or ‘often or a lot’ (2) experienced the
complaints. In the TRAILS cohort, the internal consistency for the
Physical Complaints subscale was α=0.75 at T5, and α=0.78 at T6.
In the main analysis, a mean score ranging from 0 to 2, including all 12
items, was used as an outcome measure. Analyses for dimensions of FSS
were performed with the component scores found in Principal Com-
ponent Analysis (PCA) of the Physical Complaints subscale of ASR, in
order to explore if the relationship between PA and FSS was different
for dimensions of FSS.
2.2.2. Positive and negative affect
PA and NA were measured with the Positive and Negative Affect
Schedule (PANAS) [21]. The questionnaire asks to what extent the
participants have felt 10 positive emotions and 10 negative emotions in
the last month. The answers vary from “very slightly or not at all” (1) to
“extremely” (5). The scores can range from 10 to 50 for each dimension.
In the TRAILS cohort, the internal consistency of the PANAS at T5 was
high for PA (α=0.83) as well as for NA (α=0.89). In the TRAILS
cohort, PA and NA have a correlation of r=−0.10 at T5 which sup-
ports the hypothesis of independence of both constructs.
2.2.3. Socioeconomic status
Socioeconomic Status (SES) of the parents was measured at T1 and
T4. The measure of parental SES was obtained by averaging five stan-
dardized variables: education level of both parents, occupational level
of both parents, and household income. A continuous variable of SES
was obtained and it was later categorized into lowest 25% SES, middle
50% SES and highest 25% SES to facilitate interpretation. For the main
analysis, 103 participants lacked information on SES at T4, therefore,
data from SES at T1 was used for them. The correlation between SES at
T1 and SES at T4 was r=0.85.
2.3. Statistical analysis
2.3.1. Missing data
Cases with data from both the predictor (PA) at T5 and the outcome
(FSS) at T6 were selected for analysis. Differences between included
and non-included cases were tested with independent sample t-test (PA,
NA, and age), Mann-Whitney test (FSS) and Chi-Square test (sex and
SES).
2.3.2. The relationship between PA and FSS
Multivariable linear regressions with bootstrapping were used to
test the association between PA and FSS. Bootstrapping of 1000 samples
with Bias Corrected and Accelerated (BCa) Confidence Intervals was
performed in all analyses because the outcome measures were posi-
tively skewed, and the homoscedasticity assumption for performing
linear regression was not met. The effects of a predictor were con-
sidered significant if 0 was not included in the BCa confidence intervals.
First, cross-sectional analyses were performed with FSS mean score at
T5 as the outcome, and PA at T5 as the predictor (Model 1). Sex, SES,
age at T5, and NA at T5 were subsequently added as covariates (Model
2). Second, to test if PA predicted changes in FSS over time, long-
itudinal analyses were performed with FSS mean score at T6 as the
outcome, and PA at T5 as the predictor (Model 3). FSS at T5 was added
as a covariate as well as sex, SES, age at T5 and NA at T5 (Model 4). In
A. Acevedo-Mesa, et al. Journal of Psychosomatic Research 127 (2019) 109847
2
both cases, SES was used as a categorical variable, for which two
dummy variables (middle SES, and highest SES) were entered into the
model.
2.3.3. The interaction between PA and NA, and PA and sex
Interactions between PA and NA, and PA and sex were tested cross-
sectionally and longitudinally, with linear regression with boot-
strapping.
2.3.4. Dimension analysis
A PCA was performed on the Physical Complaints subscale of ASR at
T5 and T6. In order to facilitate the interpretation of the components,
oblique rotation was used because we assumed that the components
were correlated. The optimal number of components was identified by a
scree plot and Eigenvalue ≥1. Additionally, we computed component
scores for each component, as the raw item responses weighted by the
component loading. Due to the rotation used in the PCA, the loadings of
items on one of the components were negative. For this reason, the
scores of that component were multiplied by - 1 to ensure that high
scores reflected a higher score on this component. Next, regression
analyses with bootstrapping were performed with the dimensions found
in the PCA. The associations between PA and each component of the
FSS subscale found in the PCA were tested cross-sectionally (Model 5)
and longitudinally (Model 6). Sex, SES, age at T5, and NA at T5 were
used as covariates. The scores of each of the components at T5 were
used as covariates for the longitudinal analysis in order to examine
changes in component scores.
3. Results
3.1. Descriptive statistics
After excluding cases without data on PA at T5 and FSS at T6
(n=370), the sample consisted of 1247 participants. From these,
59.9% were females and 40.1% were male. Regarding SES, 23.2% were
in the lowest, 49.0% on the middle, and 27.4% on the highest SES
group. Table 1 shows the descriptive statistics of the main variables on
both waves of assessment.
Included and excluded cases, did not differ on PA (p= .87), NA
(p= .87), and FSS (p= .37). Differences in age were significant
(p < .001), but the mean difference was very small (−0.26 years).
Within the excluded cases there were significantly less people from the
highest SES group (Lowest SES=104 cases, Middle SES=190 cases,
Highest SES=74 cases [p < .001]), as well as more males
(Males= 115, Females= 74 [p < .001]).
3.2. The relationship between PA and FSS
The results of the cross-sectional and longitudinal analysis of the
relationship between PA and FSS are shown in Table 2. In the cross-
sectional analysis, PA predicted 1.8% of the variance and had a sig-
nificant negative association with FSS at T5 (Model 1). When covariates
were added (Model 2), the model predicted 31% of the variance, and all
the variables, except for age, had a significant association with FSS. PA
had a significant negative association with FSS, meaning that an in-
crease of one unit on PA score represented a reduction in the score of
FSS by 0.004 points on a scale of 0 to 2 points. This means that a person
with the maximum score on PA (50 points) shows a decrease of 0.16
(8%) points on the FSS scale, compared with a person with the
minimum score on PA (10 points).
In the longitudinal analysis, PA predicted 1.3% of the variance and
had a significant negative association with FSS at T6 (Model 3). When
the covariates were added to the model (Model 4), PA did not sig-
nificantly predict FSS at T6.
Sensitivity analyses excluding participants with chronic diseases
(asthma and migraine) provided comparable results (results available
upon request).
3.3. Interaction analysis
The interaction between PA and NA was not significant in the cross-
sectional analysis (B= 0.000; SE=0.000; p= .063; BCa 95%
CI= [−0.001; 0.000]) nor in the longitudinal analysis (B=0.000;
SE= 0.000; p= .336; BCa 95% CI= [−0.001; 0.000]).
The interaction between PA and sex was also not significant in the
cross- sectional analysis (B=−0.004; SE=0.003; p= .171; BCa 95%
CI= [−0.009; 0.002]), nor in the longitudinal analysis (B=0.001;
SE= 0.003; p= .829; BCa 95% CI= [−0.006; 0.007]).
3.4. Dimension analysis
3.4.1. PCA
Table 3 shows the results of the PCA. The Kaiser-Meyer-Olkin
Measure of Sampling Adequacy (T5=0.85; T6=0.87), showed that
the sampling is adequate for structure detection, and the Bartlett's test
of sphericity (T5= p < .001, T6= p < .001) showed that there are
correlations between the items; therefore PCA is suitable for the sub-
scale in both waves of assessment. A two-component solution was found
in both waves, with all items loading highest on one of the components
(r > 0.3). The items loading higher in component one were associated
with “General Physical Symptoms” (e.g. feeling dizzy or tired, un-
specific pain, palpitations) while component two was related to “Gas-
trointestinal Symptoms” (e.g. nausea, abdominal pain, and vomiting).
The item “Headache” loaded higher in component two at T5, and on
component one at T6.
3.4.2. The relationship between PA and the dimensions of FSS
Table 4 shows the cross-sectional relationship between PA and each
of the components. PA had a negative significant association with the
component “General Physical Symptoms” (Model 5a), but not with the
component “Gastrointestinal Symptoms” (Model 5b), meaning that
higher levels of PA are associated with current lower levels of general
physical symptoms. Since the factor structure was slightly different at
T5 and T6, we repeated these analyses applying either the structure of
FSS at T5 or the structure at T6 to both waves. These analyses showed
comparable results as our original analyses (results available upon re-
quest).
Table 5 shows the longitudinal relationship between PA and each
component. PA was not longitudinally associated with any of the




Age. Mean (SD) 22.20 (0.64) 25.60 (0.60)
Functional Somatic Symptoms. Median (IQR) 0.17 (0.33) 0.25 (0.33)
Positive Affect. Mean (SD) 35.09 (5.25) 34.21 (5.64)








Note: SD= Standard deviation. IQR= Interquartile range. Valid cases: Age,
FSS, PA, NA, Sex=1247, Socioeconomic Status= 1240.




To our knowledge, this is the first study to explore the association
between PA and FSS in a young non-clinical sample, as well as the
potential interaction effects of NA and sex on the relationship between
PA and FSS. Firstly, we found that high PA was significantly associated
with current lower levels of FSS. The association remained significant
after adjusting for NA, age, sex, and SES. However, the size of the as-
sociation that we found was small, and at a longitudinal level, PA did
not predict changes in FSS over time. Cross-sectionally, an increase of
one unit on PA score represents a reduction in the score of FSS by 0.004
points on a scale of 0 to 2 points, which may not be considered clini-
cally relevant. Secondly, we did not find an interaction between PA and
NA or PA and sex in the prediction of FSS.
4.2. Main findings in context
The cross-sectional relationship found between PA and FSS is con-
sistent with the findings from De Gucht, Fischler, and Heiser [28],
suggesting that high levels of PA are related to current low levels of FSS.
However, this finding should be interpreted with caution. Unlike De
Gucht et al. [29], we did not find a longitudinal association between PA
and FSS. When FSS at T5 was added as a covariate for longitudinal
analysis, the association between PA and FSS disappeared and most of
the variance of FSS at T6 was predicted by FSS at T5. This could suggest
that the association found at a cross-sectional level represents a re-
versed causation and that higher PA is a result of current lower levels of
FSS. A potential explanation for the discrepancy between our study and
Table 2
The cross-sectional and longitudinal association between PA and FSS.
Cross-sectional Bootstrapped regressions Adjusted R square
Model 1 B (SE) p-value BCa 95% CI 0.018
Positive affect −0.006 (0.002) 0.001 [−0.010; −0.004]
Model 2 0.31
Positive affect −0.004 (0.001) 0.001 [−0.006; −0.002]
Negative affect 0.018 (0.001) 0.001 [0.015; 0.020]
Age −0.005 (0.010) 0.627 [−0.023; 0.013]
Female sex 0.098 (0.012) 0.001 [0.075; 0.122]
Middle SES −0.033 (0.016) 0.034 [−0.063; −0.005]
Highest SES −0.047 (0.017) 0.007 [−0.080; −0.016]
Longitudinal Bootstrapped regressions Adjusted R square
Model 3 0.013
Positive affect −0.006 (0.002) 0.001 [−0.010, −0.003]
Model 4 0.31
Positive affect −0.002 (0.001) 0.181 [−0.005, 0.001]
Negative affect 0.006 (0.001) 0.001 [0.003, 0.008]
Age −0.006 (0.010) 0.514 [−0.025, 0.012]
Female sex 0.058 (0.013) 0.001 [0.035, 0.080]
Middle SES −0.002 (0.017) 0.888 [−0.038, 0.031]
Highest SES −0.014 (0.019) 0.462 [−0.053, 0.025]
FSS at T5 0.480 (0.037) 0.001 [0.410, 0.550]
Note: PA at T5 as predictor and FSS at T5 as the outcome in cross-sectional analysis. FSS at T6 as the outcome in the longitudinal analysis. B= unstandardized
coefficient, SE= standard error, BCa 95% CI=Bias Corrected and Accelerated 95% Confidence Interval. Sex: “Male” as the reference group, SES: “Lowest SES” as
the reference group.
Table 3
Principal component analysis (PCA) of physical complaints subscale from ASR at T5 and at T6.
Item T5 T6
Component 1 Component 2 Component 1 Component 2
I feel dizzy or light in my head 0.61 −0.03 0.65 −0.07
I feel tired without my knowing why 0.68 0.07 0.64 −0.01
Physical problems without known medical cause:
Pains (no abdominal or headache) 0.58 −0.03 0.53 −0.21
Headache 0.26 −0.53 0.53 −0.20
Nausea 0.21 −0.70 0.27 −0.70
Eye problems (for which glasses or lenses do not help) 0.40 0.04 0.43 0.04
Skin rash or other skin problems 0.32 −0.08 0.41 0.17
Abdominal pain 0.17 −0.68 0.35 −0.55
Vomiting −0.22 −0.75 −0.16 −0.85
Palpitations 0.51 −0.09 0.59 −0.02
Death sensation or tingling in body parts 0.58 −0.01 0.64 0.03
I have problems sleeping 0.55 0.04 0.54 −0.08
Note: Items loading>0.30 are in boldface.
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the study of De Gucht et al. [29] is the study sample. In their study, a
clinical sample of 377 adults was included, whereas we used a large
population-based sample of young adults. PA could be more relevant
for predicting changes in FSS in patients who already present with
symptoms, compared with young adults from the general population.
Regarding the interaction analyses, we did not find evidence that
males or females were more sensitive to the effects of PA on FSS. The
studies that found a difference by sex focused on chronic pain and al-
lostatic load [26,31], which reflect chronic manifestations of symp-
toms. In our study, FSS may not have been chronic yet; therefore, it
could be the case that the effects of PA interact with sex only in chronic
FSS. Another possibility is that, as FSS scores were very low, a floor
effect would not allow observing a potential interaction effect between
PA and other variables. According to our knowledge, no previous stu-
dies have examined the interaction between PA and NA, and its asso-
ciation with FSS. We expected that a combination of high PA and low
NA would be more strongly related to lower levels of FSS; however, we
did not find an interaction between them. We did find that both con-
structs had independent contributions to FSS, especially NA which
predicted both current FSS and changes in FSS over time. This is con-
sistent with the findings of previous studies, linking NA with FSS
[11,16,20,28,29].
4.3. FSS dimensions
In the PCA, two dimensions of the physical complaints subscale of
the ASR were found: A General Physical Symptoms dimension and a
Gastrointestinal Symptoms dimension. In the secondary cross-sectional
analyses, higher levels of PA were associated with lower levels of
symptoms on both dimensions, but the association was only significant
for the “General physical symptoms” dimension. In the longitudinal
analysis, PA was not a significant predictor of changes in “General
physical symptoms” nor “Gastrointestinal symptoms”.
Two previous studies from the TRAILS cohort performed a PCA on
the physical complaints subscale of the Youth-Self Report ques-
tionnaire. In adolescents between 11 and 16 years old, one dimension
was found to underlie the construct of FSS [4]. In a subsample of
adolescents with a mean age of 16 years, the PCA revealed that FSS
were better explained by two dimensions: one consisting of headache
and gastrointestinal symptoms and the other consisting of over-
tiredness, dizziness and musculoskeletal pain [32]. The results of our
PCA in young adults reveal a similar dimension structure at T5 with the
item “headache” loading in the gastrointestinal symptoms dimension.
We found slight differences between the factor structures at T5 and T6,
but these did not influence our results on the associations with PA. An
Table 4
The relationships between PA and current general physical symptoms, and PA and current gastrointestinal symptoms.
Cross-sectional Bootstrapped regressions Adjusted R square
General physical symptoms (Component 1)
Model 5a B(SE) p-value BCa 95% CI 0.28
Positive affect −0.019 (0.005) 0.001 [−0.028; −0.011]
Negative affect 0.069 (0.005) 0.001 [0.061; 0.077]
Age 0.033 (0.035) 0.351 [−0.035; 0.101]
Female sex 0.304 (0.043) 0.001 [0.218; 0.395]
Middle SES −0.091 (0.058) 0.129 [−0.206; 0.024]
Highest SES −0.119 (0.061) 0.059 [−0.235; −0.009]
Gastrointestinal symptoms (Component 2)
Model 5b 0.18
Positive affect −0.008 (0.004) 0.081 [−0.016; 0.001]
Negative affect 0.048 (0.004) 0.001 [0.041; 0.056]
Age −0.016 (0.037) 0.663 [−0.090; 0.560]
Female sex 0.380 (0.044) 0.001 [0.289; 0.463]
Middle SES −0.119 (0.061) 0.056 [−0.240; 0.011]
Highest SES −0.245 (0.061) 0.001 [−0.363; −0.139]
Note: PA at T5 as the predictor and each component at T5 as the outcome. B= unstandardized coefficient, SE= standard error, BCa 95% CI=Bias Corrected and
Accelerated 95% Confidence Interval. Sex: “Male” as the reference group, SES: “Lowest SES” as the reference group.
Table 5
The relationships between PA and changes in general physical symptoms, and PA and changes in gastrointestinal symptoms.
Longitudinal Bootstrapped regressions Adjusted R square
General physical symptoms (Component 1)
Model 6a B(SE) p-value BCa 95% CI 0.32
Positive affect −0.006 (0.005) 0.196 [−0.017; 0.004]
Negative affect 0.020 (0.004) 0.001 [0.011; 0.029]
Age −0.026 (0.035) 0.469 [−0.093; 0.043]
Female sex 0.184 (0.044) 0.001 [0.093; 0.272]
Middle SES −0.026 (0.062) 0.682 [−0.167; 0.109]
Highest SES −0.081 (0.071) 0.263 [−0.228; 0.070]
Comp. 1 at T5 0.451 (0.033) 0.001 [0.391; 0.511]
Gastrointestinal symptoms (Component 2)
Model 6b 0.09
Positive affect 0.001 (0.006) 0.894 [−0.011; 0.012]
Negative affect 0.005 (0.005) 0.280 [−0.004; 0.015]
Age −0.041 (0.039) 0.297 [−0.120; 0.038]
Female sex 0.243 (0.055) 0.001 [0.142; 0.341]
Middle SES 0.017 (0.067) 0.790 [−0.118; 0.144]
Highest SES −0.017 (0.074) 0.827 [−0.177; 0.137]
Comp. 2 at T5 0.244 (0.042) 0.001 [0.164; 0.331]
Note: PA at T5 as the predictor and each component at T6 as the outcome. B= unstandardized coefficient, SE= standard error, BCa 95% CI=Bias Corrected and
Accelerated 95% Confidence Interval. Sex: “Male” as the reference group, SES: “Lowest SES” as the reference group.
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explanation for these differences might be that FSS start clustering and
differentiating with aging, before becoming chronic or developing into
syndromes. Although one study found that all depressive and anxiety
disorders, except for dysthymic disorder, were independently asso-
ciated with all dimensions of somatic symptoms [36], the results of the
current study suggest that both PA and NA are more strongly related to
the general physical symptoms dimension than to the gastrointestinal
symptoms dimension.
4.4. Strengths
One of the main strengths of this study is the large sample size of
this population-based cohort and the high response rate of the partici-
pants at both waves. Well-validated and reliable instruments were used
for measuring all variables. The incorporation of PCA in the study, to
assess the validity of the dimensional structure of the outcome measure,
also gives strength to this study.
4.5. Limitations
This study has several limitations. Firstly, FSS were assessed by self-
report. Chronic diseases may have contributed to the negative asso-
ciation between PA and FSS in the cross-sectional analysis. However,
excluding participants with asthma and migraine, two of the most
common chronic diseases in this age group, did not alter the associa-
tions. Secondly, since this study was performed in young adults from
the general population, few of them may have had severe FSS, which
could have reduced the strength of the association between PA and FSS.
Thirdly, this study assessed the variation in PA and FSS levels between
individuals, but it did not measure the variations in PA and FSS within
individuals. This may have made the association appear smaller since
the within-person variability in PA and FSS is not taken into account. A
study from Schenk et al. found a non-significant cross-sectional asso-
ciation between PA and general somatic symptoms at a between-sub-
jects level, but a significant negative association at a within-subjects
level, revealing individual processes [37].
4.6. Future research
Considering the results of this study, it is worthwhile to keep ex-
ploring the relationship between PA and FSS in older populations. As
FSS seem to increase with age [15,38], studying the associations be-
tween PA and FSS in older populations could give more information
about the role of PA in FSS, as in these populations the FSS may be more
severe and may become chronic or develop into functional somatic
syndromes (e.g. fibromyalgia). It is also necessary to explore within-
person differences in order to assess if the association between PA and
FSS is stronger or weaker depending on individual variability. Given
that PA can have day-to-day variations, and these are individual-spe-
cific, it is important to assess the influence of affect in the manifestation
of FSS in a shorter time frame. This could be done by means of Intensive
Longitudinal Measurement, where daily within-individual variations
can be modeled both in PA and in FSS. This could provide more ac-
curate estimates of the relationship. Moreover, since negative affective
states have been found to be related to FSS, it would be relevant to
explore the within-person variability in both PA, NA, and their in-
dependent and interactive associations with specific FSS and clusters of
symptoms.
5. Conclusion
High PA was significantly related to current lower levels of FSS in
young adults; however, PA did not predict changes in FSS over time.
Neither NA nor sex modified the association of PA with FSS. The as-
sociation between PA and current FSS should be interpreted with cau-
tion and further studies are necessary to unravel the associations
between affect and FSS. Although the results are significant at a cross-
sectional level, the effect size is small and therefore the relevance of this
study is theoretical rather than clinical.
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